McKesson Corporation (MCK) Shares are Up 0.05%

McKesson Corporation (MCK) : During the past 4 weeks, traders have been relatively bearish on McKesson Corporation (MCK), hence the stock is down -1.48% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -0.37% relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 0.05% in the last 1 week, and is up 0.97% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

McKesson Corporation (NYSE:MCK): During Fridays trading session, Bulls were in full control of the stock right from the opening. The stock opened at $195.06 and $194.52 proved to be the low of the day. Continuous buying at higher levels pushed the stock towards an intraday high of $196.63. The buying momentum continued till the end and the stock did not give up its gains. It closed at $194.66, notching a gain of 0.09% for the day. The total traded volume was 1,029,238 . The stock had closed at $194.48 on the previous day.

The stock has recorded a 20-day Moving Average of 0.53% and the 50-Day Moving Average is 3.39%. McKesson Corporation is up 15.45% in the last 3-month period. Year-to-Date the stock performance stands at -0.97%.

McKesson Corporation (MCK) : The highest short term price target forecast on McKesson Corporation (MCK) is $230 and the lowest target price is $172. A total of 10 equity analysts are currently covering the company. The average price of all the analysts is $202.2 with a standard deviation of $18.88.


McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.